logo

NBRV(Delisted)

Nabriva TherapeuticsยทNASDAQ
--
--(--)

NBRV Profile

Nabriva Therapeutics Plc

A biopharmaceutical company that developing innovative anti-infective agents to treat serious infections

--
--
09/18/2015
NASDAQ Stock Exchange
24
12-31
Common stock
Alexandra House, Office 225/227, The Sweepstakes, Dublin 4, Ireland
--
Nabriva Therapeutics plc was founded in Austria in October 2005. On March 1, 2017, the company was incorporated in Ireland. The company is a clinical-stage biopharmaceutical company engaged in the development of new anti-infective drugs for the treatment of serious infections, mainly developing antibiotics for pleuromutilin.